You are currently on the International (English) version.
Looks like you are in United States.
Switch to local content?
Reflections on durable therapies for diabetic macular edema amid COVID-19 pandemic
An article in Ophthalmology Times by Dr. Caesar Luo overviews considerations for sustainable DME management options during the everchanging COVID-19 healthcare landscape, with an emphasis on the backlog caused by patients’ reluctance to visit clinics during the pandemic. It includes an interesting case study imaged using a SPECTRALIS OCT.
An article in Ophthalmology Times by Dr. Caesar Luo overviews considerations for sustainable DME management options during the everchanging COVID-19 healthcare landscape, with an emphasis on the backlog caused by patients’ reluctance to visit clinics during the pandemic. It includes an interesting case study imaged using a SPECTRALIS OCT.
Courtesy of Ophthalmology Times, Durable therapies for diabetic macular edema amid COVID-19 pandemic.